Profile data is unavailable for this security.
About the company
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
- Revenue in EUR (TTM)19.64bn
- Net income in EUR718.19m
- Incorporated2006
- Employees109.92k
- LocationFresenius Medical Care AGElse-Kroener-Strasse 1BAD HOMBURG VOR DER HOHE 61352GermanyDEU
- Phone+49 61726090
- Fax+49 61 726092301
- Websitehttps://www.freseniusmedicalcare.com/
| Holder | Shares | % Held |
|---|---|---|
| Dodge & Coxas of 03 Jul 2025 | 14.60m | 4.98% |
| Pzena Investment Management LLCas of 30 Jan 2026 | 8.79m | 3.00% |
| Artisan Partners LPas of 19 Aug 2025 | 8.79m | 3.00% |
| Harris Associates LPas of 14 Apr 2025 | 8.75m | 2.98% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 8.08m | 2.75% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 4.58m | 1.56% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 3.38m | 1.15% |
| Geode Capital Management LLCas of 12 Feb 2026 | 3.08m | 1.05% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 2.72m | 0.93% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 2.23m | 0.76% |
